Fabry's disease with partially deficient hydrolysis of ceramide trihexoside.
A report is presented on biochemical studies of the fibroblasts from a 26-year-old man with Fabry's disease whose clinical picture was atypical. The patient had severe pain in the extremities, but no angiokeratomas, corneal clouding or hypohidrosis. The trihexosylceramidase activity in the fibroblasts in vitro was deficient. The level and Km value of the residual activity were similar to levels seen in typical Fabry's patients. However, fibroblasts from the patient cultured in medium supplemented with [3H]ceramide trihexoside hydrolyzed the labeled ceramide trihexoside much higher than did cells from typical Fabry's patients, implying that the patient has a partial defect in hydrolysis of trihexosylceramide in cultured fibroblasts.
Kobayashi
T
T
Kira
J
J
Shinnoh
N
N
Goto
I
I
Kuroiwa
Y
Y
D000328:Adult; D002478:Cells, Cultured; D000795:Fabry Disease / Q000235:genetics / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism; D006028:Glycosphingolipids / Q000378:metabolism*; D006801:Humans; D006868:Hydrolysis; D008297:Male; D014281:Trihexosylceramides / Q000378:metabolism*; D000519:alpha-Galactosidase / Q000378:metabolism
D006028:Glycosphingolipids; D014281:Trihexosylceramides; D000519:alpha-Galactosidase